NCT05038449View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 6, 2021

Primary Completion Date

June 1, 2023

Study Completion Date

September 1, 2023

Conditions
Covid19Colchicine
Interventions
DRUG

Colchicine Tablets

Colchicine Tablets (Each tablet contains colchicine 0.5mg)

DRUG

Standard therapy

Standard therapy for COVID-19 according to the Novel Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial 8th Edition)

Trial Locations (1)

201508

Shanghai Public Health Clinical Center, Shanghai

Sponsors
All Listed Sponsors
collaborator

Kunming Pharmaceuticals, Inc.

INDUSTRY

lead

Shanghai Public Health Clinical Center

OTHER_GOV